Bruker (BRKRP) Cash & Current Investments (2009 - 2026)

Bruker has reported Cash & Current Investments for 18 years, with the latest figure at $161.6 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Current Investments fell 15.88% year-over-year to $161.6 million; the trailing twelve-month figure through Mar 2026 stood at $161.6 million (down 15.88% YoY), and the FY2025 full-year result was $322.6 million, up 68.9% from the prior year.
• Cash & Current Investments for Q1 2026 stood at $161.6 million, down from $322.6 million in the prior quarter.
• The five-year high for Cash & Current Investments was $916.1 million in Q1 2022, with the low at $124.8 million in Q2 2025.
• Historically, Cash & Current Investments has averaged $412.0 million across 5 years, with a median of $363.6 million in 2023.
• Annual changes were most pronounced in 2024 — Cash & Current Investments sank 64.89% — and 2025, when it jumped 68.9%.
• Bruker's Cash & Current Investments stood at $660.3 million in 2022, then declined by 24.23% to $500.3 million in 2023, then tumbled by 61.82% to $191.0 million in 2024, then jumped by 68.9% to $322.6 million in 2025, then sank by 49.91% to $161.6 million in 2026.
• The last three Cash & Current Investments figures came in at $161.6 million (Q1 2026), $322.6 million (Q4 2025), and $297.0 million (Q3 2025), per Business Quant data.